BCG vaccination in South African HIV-exposed infants : risks and benefits

The original publication is available at
BCG vaccine, DNA polymerase, Virus DNA, BCG vaccination, Drug contraindication, Health care policy, Human immunodeficiency virus, Human immunodeficiency virus infected patient, Human immunodeficiency virus infection, Lung tuberculosis, Lymphadenitis, Mycobacterium tuberculosis, Risk benefit analysis, Single drug dose, South Africa, Vertical transmission, World health organization, Disease transmission, Drug administration, Immunology, Infants, Newborns, Risk assessment, Serodiagnosis, Tuberculosis, Adjuvants, Immunologic, Drug administration schedule, Health policy, HIV infections, HIV Seronegativity, Risk assessment
Hesseling, AC 2009, BCG vaccination in South African HIV-exposed infants - Risks and benefits, South African Medical Journal, vol. 99(2) 88-93,